CONMED Stock Options
| CNMD Stock | USD 68.76 0.22 0.32% |
CONMED's latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.59. The CONMED option chain provides detailed quote and price information for the current CONMED option contracts. It shows all of CONMED's listed puts, calls, expiration dates, strike prices, and other pricing information.
CONMED Maximum Pain Price Across 2025-01-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as CONMED close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, CONMED's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on CONMED
Analyzing CONMED's in-the-money options over time can help investors to take a profitable long position in CONMED regardless of its overall volatility. This is especially true when CONMED's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money CONMED's options could be used as guardians of the underlying stock as they move almost dollar for dollar with CONMED's stock while costing only a fraction of its price.
CONMED's stock options are financial instruments that give investors the right to buy or sell shares of CONMED common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell CONMED stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If CONMED's stock price goes up or down, the stock options follow.
At present, CONMED's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 521.1 M, whereas Common Stock Total Equity is forecasted to decline to about 317.6 K. CONMED In The Money Call Balance
When CONMED's strike price is surpassing the current stock price, the option contract against CONMED stock is said to be in the money. When it comes to buying CONMED's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on CONMED are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
CONMED Current Options Market Mood
CONMED's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps CONMED Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of CONMED's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. CONMED's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current CONMED contract
Base on the Rule 16, the options market is currently suggesting that CONMED will have an average daily up or down price movement of about 0.0369% per day over the life of the 2025-01-17 option contract. With CONMED trading at USD 68.76, that is roughly USD 0.0254. If you think that the market is fully incorporating CONMED's daily price movement you should consider buying CONMED options at the current volatility level of 0.59%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
CONMED |
Purchasing CONMED options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" CONMED calls. Remember, the seller must deliver CONMED stock to the call owner when a call is exercised.
CONMED Option Chain
When CONMED's strike price is surpassing the current stock price, the option contract against CONMED stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
CONMED's option chain is a display of a range of information that helps investors for ways to trade options on CONMED. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for CONMED. It also shows strike prices and maturity days for a CONMED against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CNMD250117C00040000 | 0 | 40.0 | 29.2 - 33.7 | 29.2 | In |
Call | CNMD250117C00045000 | 0 | 45.0 | 24.5 - 29.0 | 24.5 | In |
Call | CNMD250117C00050000 | 0 | 50.0 | 20.3 - 24.0 | 20.3 | In |
Call | CNMD250117C00055000 | 0 | 55.0 | 15.3 - 19.4 | 15.3 | In |
Call | CNMD250117C00060000 | 0 | 60.0 | 10.9 - 15.0 | 10.9 | In |
Call | CNMD250117C00065000 | 0 | 65.0 | 6.4 - 11.0 | 6.4 | In |
Call | CNMD250117C00070000 | 0 | 70.0 | 3.3 - 7.5 | 3.3 | In |
Call | CNMD250117C00075000 | 0 | 75.0 | 1.3 - 5.0 | 1.3 | |
Call | CNMD250117C00080000 | 0 | 80.0 | 0.1 - 4.9 | 0.1 | |
Call | CNMD250117C00085000 | 0 | 85.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00040000 | 0 | 40.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00045000 | 0 | 45.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00050000 | 0 | 50.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00055000 | 0 | 55.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00060000 | 0 | 60.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00065000 | 0 | 65.0 | 0.0 - 4.8 | 4.8 | |
Put | CNMD250117P00070000 | 0 | 70.0 | 2.8 - 5.5 | 2.8 | |
Put | CNMD250117P00075000 | 0 | 75.0 | 3.8 - 8.5 | 3.8 | In |
Put | CNMD250117P00080000 | 0 | 80.0 | 7.0 - 11.6 | 7.0 | In |
Put | CNMD250117P00085000 | 0 | 85.0 | 11.5 - 16.3 | 11.5 | In |
CONMED Total Stockholder Equity
Total Stockholder Equity |
|
CONMED Corporate Directors
| John Workman | Independent Director | Profile | |
| Charles Farkas | Independent Director | Profile | |
| Jerome Lande | Independent Director | Profile | |
| David Bronson | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.14 | Dividend Share 0.8 | Earnings Share 4.22 | Revenue Per Share | Quarterly Revenue Growth 0.04 |
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.